Gap-134, a Connexin43 activator, prevents age-related development of ventricular fibrosis in Scn5a+/- mice.
Patin J, Castro C, Steenman M, Hivonnait A, Carcouët A, Tessier A, Lebreton J, Bihouée A, Donnart A, Le Marec H, Baró I, Charpentier F, Derangeon M.
Patin J, et al. Among authors: derangeon m.
Pharmacol Res. 2020 Sep;159:104922. doi: 10.1016/j.phrs.2020.104922. Epub 2020 May 25.
Pharmacol Res. 2020.
PMID: 32464326